| # | Drug | Count |
|---|---|---|
| 0 | TRASTUZUMAB | 10 |
| 1 | CONJUGATED ESTROGENS | 9 |
| 2 | ESTROGENS, CONJUGATED | 9 |
| 3 | MEDROXYPROGESTERONE ACETATE | 8 |
| 4 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 6 |
| 5 | ADO-TRASTUZUMAB EMTANSINE | 5 |
| 6 | ALENDRONATE SODIUM | 4 |
| 7 | PACLITAXEL | 4 |
| 8 | PERTUZUMAB | 4 |
| 9 | CELECOXIB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 1 | 0.0027 |
| 1 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 1 | 0.0027 |
| 2 | ESTRADIOL CYPIONATE | 1 | 0.0017 |
| 3 | DIFLUNISAL | 1 | 0.0012 |
| 4 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 5 | ADO-TRASTUZUMAB EMTANSINE | 5 | 0.0006 |
| 6 | TAMOXIFEN CITRATE | 3 | 0.0005 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 8 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 6 | 0.0003 |
| 9 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 10 |
| 1 | Estrogen [EPC] | 9 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 3 | Microtubule Inhibitor [EPC] | 5 |
| 4 | Benzodiazepine [EPC] | 4 |
| 5 | Osmotic Laxative [EPC] | 4 |
| 6 | Loop Diuretic [EPC] | 3 |
| 7 | Potassium Salt [EPC] | 3 |
| 8 | Thiazide Diuretic [EPC] | 3 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | HER2/neu Receptor Antagonist [EPC] | 10 | 0.0001 |
| 1 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 2 | Estrogen [EPC] | 9 | 0.0000 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 4 | Alkaloid [EPC] | 1 | 0.0000 |
| 5 | Androgen [EPC] | 1 | 0.0000 |
| 6 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 7 | Microtubule Inhibitor [EPC] | 5 | 0.0000 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |